Balloon Catheter

This channel includes news and new technology innovations for angioplasty balloon catheters (PTA). These are used in arteries with atherosclerotic lesions to compress the plaque expand the artery lumen to reopen occluded or heavily stenosed atherosclerotic lesions. Balloons are often used in combination with a stent to prop the treated vessel segment open. In addition to plain old balloon angioplasty (POBA), this section includes news about drug-coated balloon (DCB), valvuloplasty balloons and specialty cutting balloon.

Technology | Drug-Eluting Balloons

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact Admiral ...

Home May 03, 2018
Home
Serial coronary angiograms of the representative case treated with shockwave intravascular lithotripsy.
Feature | Cath Lab | Azeem Latib, M.D.

Over the last decade, there have been considerable developments in procedural techniques and technology facilitating the ...

Home April 16, 2018
Home
Technology | Balloon Catheter

March 21, 2018 — Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) ...

Home March 21, 2018
Home
News | Drug-Eluting Balloons

February 7, 2018 — Medtronic plc recently added to its body of clinical evidence supporting the In.Pact Admiral drug ...

Home February 07, 2018
Home
News | Balloon Catheter

January 24, 2018 — Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product ...

Home January 24, 2018
Home
News | Peripheral Artery Disease (PAD)

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (PTA ...

Home December 29, 2017
Home
The B. Braun Sequent Please drug-eluting balloon.
Feature | Drug-Eluting Balloons

November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...

Home November 02, 2017
Home
News | EP Lab

September 27, 2017 — Spectranetics is recalling its Bridge Occlusion Balloon Catheter due to the possibility of a ...

Home September 27, 2017
Home
News | Drug-Eluting Balloons

September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...

Home September 18, 2017
Home
News | Peripheral Artery Disease (PAD)

September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...

Home September 13, 2017
Home
News | Drug-Eluting Balloons

September 13, 2017 — Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from ...

Home September 13, 2017
Home
Technology | Drug-Eluting Balloons

August 29, 2017 — C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted ...

Home August 29, 2017
Home
News | Drug-Eluting Balloons

August 15, 2017 — Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and ...

Home August 15, 2017
Home
Technology | Drug-Eluting Balloons

July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval ...

Home July 26, 2017
Home
Philips acquires purchases Spectranetics
Feature | Cardiovascular Business

June 28, 2017 — Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger ...

Home June 28, 2017
Home
Subscribe Now